[New therapies turn oral steroids into reserve agents].
.
Dirk
D
Einecke
D000280:Administration, Inhalation; D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage* / Q000009:adverse effects; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D004802:Eosinophilia / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D015848:Interleukin-5 / Q000037:antagonists & inhibitors; D008134:Long-Term Care; D000069444:Omalizumab / Q000008:administration & dosage* / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D061067:Antibodies, Monoclonal, Humanized; D015848:Interleukin-5; D000069444:Omalizumab; D007073:Immunoglobulin E; C434107:mepolizumab